Literature DB >> 21555943

Clinical trials for pharmacogenomics testing for warfarin dosing: relevance to general community practices.

Nikoletta Sidiropoulos, Alan H B Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21555943     DOI： 10.1097/GIM.0b013e31821db51a

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  3 in total

1.  Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.

Authors:  H L Tang; W L Shi; X G Li; T Zhang; S D Zhai; H G Xie
Journal:  Pharmacogenomics J       Date:  2015-04-14       Impact factor: 3.550

2.  Warfarin pharmacogenetic trials: is there a future for pharmacogenetic-guided dosing?

Authors:  Stuart A Scott; Steven A Lubitz
Journal:  Pharmacogenomics       Date:  2014-04       Impact factor: 2.533

3.  Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin.

Authors:  Shinya Suzuki; Kiwako Ikegawa; Kaori Yamamoto; Shinichiro Saito
Journal:  J Int Med Res       Date:  2016-09-27       Impact factor: 1.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.